Source: Los Angeles Business Journal
Next month, a SpaceX rocket is set to carry an unusual payload to the International Space Station: a sample of stem cells to be cultivated as part of a Cedars-Sinai Medical Center research project to see if the cells can grow more rapidly and achieve better quality in space.
Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have turned to a silk protein, silk fibroin (SF), produced by the Bombyx mori silkworm as a biomaterial for tendon repair. The researchers report their method has yielded significant improvements in mesenchymal stem cells (MSCs) tendon regeneration.
Source: AZO Nano
An article published in the journal Biomaterials shows that CuS@MnO2 nanoparticles (NPs) synthesized with a short bacteriophage-selected mesenchymal stem cell (MSC) targeting peptide allowed the MSCs to take up these NPs. NP-modified MSCs produced greatly improved therapy of Rheumatoid Arthritis (RA) using stem cells.
A woman living with HIV in the United States may be the first female and third person to have been “cured” of HIV through stem cell transplants.
An alveolar cleft is the most common congenital bone defect. This systematic review aimed to investigate the use of stem cells for alveolar cleft repair and summarize the outcomes of clinical research studies.
One of the most promising approaches to replacing sick or damaged cells with healthy cells is cellular reprogramming, whereby one cell type in our body converts to another cell type. Research has uncovered new ways to improve the cellular reprogramming efficiency, unlocking potential for cellular repair therapies.
Source: The Scientist
The mechanical environment—how elastic the underlying substance is—influences what type of cells MSCs go on to become. Less elastic, stiff substrates promote differentiation into bone, while soft substrates favor fat.